Pepto-bismol
NDC Package 50090-0553-0

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Pepto-bismol is chew or dissolve in mouthadults and children 12 years and over:2 tablets (1 dose) every ½ hour or 4 tablets (2 doses) every hour as needed for diarrhea2 tablets (1 dose) every ½ hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)do not exceed 8 doses (16 tablets) in 24 hoursuse until diarrhea stops but not more than 2 dayschildren under 12 years: ask a doctordrink plenty of clear fluids to help prevent dehydration caused by diarrhea. Marketed by A-s Medication Solutions, this product is identified by NDC 50090-0553 and is authorized under FDA application M008.

Identification & Billing

NDC Package Code
50090-0553-0
Package Description
5 CELLO PACK in 1 CARTON / 6 TABLET in 1 CELLO PACK
Product Code
50090-0553
11-Digit Billing Format
50090055300
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
5 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Pepto-bismol
Dosage Form
-
Usage Information
Chew or dissolve in mouthadults and children 12 years and over:2 tablets (1 dose) every ½ hour or 4 tablets (2 doses) every hour as needed for diarrhea2 tablets (1 dose) every ½ hour as needed for overindulgence (upset stomach, heartburn, indigestion, nausea)do not exceed 8 doses (16 tablets) in 24 hoursuse until diarrhea stops but not more than 2 dayschildren under 12 years: ask a doctordrink plenty of clear fluids to help prevent dehydration caused by diarrhea

Regulatory & Marketing

Labeler Name
A-s Medication Solutions
FDA Application #
M008
Marketing Category
OTC MONOGRAPH FINAL - A product marketed pursuant to a final Over-the-Counter (OTC) Drug Monograph.
Start Marketing Date
06-30-2004
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50090-0553-0 identifies a specific commercial package of 5 cello pack in 1 carton / 6 tablet in 1 cello pack of Pepto-bismol, labeled by A-s Medication Solutions. This product is billed for "EA" each discreet unit and contains an estimated amount of 5 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by A-s Medication Solutions on June 30, 2004. The current certification is valid through December 31, 2024.

How is this A-s Medication Solutions product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50090055300. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
50090-0553-0
11-Digit CMS (5-4-2)
50090-0553-00

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.